Metraipolis › archive › dc_e35d77fe9b06

Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung… — Europe PMC PMID:41306970

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41306970
DOI
10.3389/fimmu.2025.1668782
License (as archived)
solo-consultazione
Archived
2026-11-08T16:17:45.151Z
SHA-256 of the archived text
1d66ca260b5a5e8002d11e11909fbdecd5227ca71c517ec7973dab8d2cf86c02
Stable URL of this page
https://metraipolis.com/documento/dc_e35d77fe9b06

How to cite

Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung… — Europe PMC PMID:41306970 — Europe PMC (en), https://europepmc.org/article/MED/41306970 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e35d77fe9b06 (Metraipolis archive dc_e35d77fe9b06, sha256 1d66ca260b5a5e8002d11e11909fbdecd5227ca71c517ec7973dab8d2cf86c02)
BibTeX
@misc{dce35d77fe9b06,
  title = {Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung… — Europe PMC PMID:41306970},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41306970},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e35d77fe9b06; sha256 1d66ca260b5a5e8002d11e11909fbdecd5227ca71c517ec7973dab8d2cf86c02},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306970. Agents can read the archived copy with the MCP tool read_document.